Modeled Fetal Risk of Genetic Diseases Identified by Expanded Carrier Screening

Imran S. Haque, PhD; Gabriel A. Lazarin, MS; H. Peter Kang, MD; Eric A. Evans, PhD; James D. Goldberg, MD; Ronald J. Wapner, MD

Importance Screening for carrier status of a limited number of single-gene conditions is the current standard of prenatal care. Methods have become available allowing rapid expanded carrier screening for a substantial number of conditions.

Objectives To quantify the modeled risk of recessive conditions identifiable by an expanded carrier screening panel in individuals of diverse racial and ethnic backgrounds and to compare the results with those from current screening recommendations.

Design, Setting, and Participants Retrospective modeling analysis of results between January 1, 2012, and July 15, 2015, from expanded carrier screening in reproductive-aged individuals without known indication for specific genetic testing, primarily from the United States. Tests were offered by clinicians providing reproductive care.

Exposures Individuals were tested for carrier status for up to 94 severe or profound conditions.

Main Outcomes and Measures Risk was defined as the probability that a hypothetical fetus created from a random pairing of individuals (within or across 15 self-reported racial/ethnic categories; there were 11 categories with >5000 samples) would be homozygous or compound heterozygous for 2 mutations presumed to cause severe or profound disease. Severe conditions were defined as those that if left untreated cause intellectual disability or a substantially shortened lifespan; profound conditions were those causing both.